| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr4_0185000 | Intergenic-Intergenic | chr4:151886960-151897082 | chr4:150965808-150975930 | 250 nt | 0.3840 |
| hsa_LRBA_0043900 | Intron-Intron | chr4:151914669-151919729 | chr4:150993517-150998577 | 250 nt | 0.3000 |
| hsa_LRBA_0044000 | Intron-Intron | chr4:151923699-151925153 | chr4:151002547-151004001 | 1455 nt | 0.4474 |
| hsa_chr4_0185100 | Intergenic-Intergenic | chr4:151926205-151926366 | chr4:151005053-151005214 | 162 nt | 0.4012 |
| hsa_LRBA_0044100 | Intron-Intron | chr4:151927015-151927275 | chr4:151005863-151006123 | 261 nt | 0.4023 |
| hsa_LRBA_0044200 | Intron-Intron | chr4:151927024-151927275 | chr4:151005872-151006123 | 252 nt | 0.4008 |
A study in mice demonstrated that the circLRBA was significantly suppressed in an acute myocardial infarction (AMI) model, with levels rapidly declining and reaching their lowest point at 15 minutes after coronary artery ligation [Gao et al. DOI:10.1016/j.legalmed.2022.102184].